HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites wiki



Is it true that Gilead made three billion in profits from the sales of Truvada in 2018 three billion in revenue oh yes in revenue thank you and very quickly at the current list. Price is two thousand dollars a month in the United. States correct the current list price is 1780 in the United States and just to correct the three billion was a global figure okay for Fortran so it so. The list price is almost two thousand dollars in the united states why is it eight dollars in australia Truvada still has patent protection in the united states and in the rest of the world. It is generic I can't comment on the price in Australia of the. Generic medicines but it is generically available in other parts of the world and will be generically available in the United. States as of September and 2020 based upon Gilead agreeing to to support so I think it's important that we notice here that. We the public we the. People develop this drug we paid for this drug we led and developed all of the grounding patents to create prep and then that patent has been privatized despite the fact that the patent is owned by the public we refuse to enforce it there is no reason that should be $2,000. A month people are dying. Because of it and and there's. No enforceable reason for it we own the intellectual the core intellectual property for it and as a result people's people are dying for no reason for no.

 


Gilead Sciences Company News

Thu, 09 May 2019 17:52:00 GMT
Gilead Sciences At The Filgotinib And Selonsertib Crossroads - Seeking Alpha
<ol><li> Gilead Sciences At The Filgotinib And Selonsertib Crossroads Seeking Alpha</font></li><li><a href="/url/?u=https://www.zacks.com/stock/news/411757/is-gilead-sciences-gild-stock-outpacing-its-medical-peers-this-year" target="_blank">Is Gilead Sciences (GILD) Stock Outpacing Its Medical Peers This Year? Zacks.com</font></li><li><a href="/url/?u=https://www.finmercury.com/2019/05/09/is-it-crazy-to-buy-gilead-sciences-inc-gild-and-ebay-inc-ebay/" target="_blank">Is It Crazy To Buy Gilead Sciences, Inc. (GILD) And eBay Inc. (EBAY)? Financial Mercury</font></li><li><a href="/url/?u=https://finbulletin.com/2019/05/09/time-to-get-returns-on-semiconductor-corporation-on-gilead-sciences-inc-gild/" target="_blank">Time To Get Returns: ON Semiconductor Corporation (ON), Gilead Sciences, Inc. (GILD) FinBulletin</font></li><li><a href="/url/?u=https://www.dwinnex.com/2019/05/08/gilead-sciences-inc-gild-price-analysis-next-bullish-target-is-81-39/" target="_blank">Gilead Sciences, Inc. [GILD] Price Analysis: Next Bullish Target is $81.39 The Dwinnex</font></li><li><strong><a href="/url/?u=https://news.google.com/stories/CAAqOQgKIjNDQklTSURvSmMzUnZjbmt0TXpZd1NoTUtFUWlldV9QeWpZQU1FUXhnTVI2LU9YM3ZLQUFQAQ?oc=5" target="_blank">View full coverage on Google News</a></strong></li></ol>
Tue, 07 May 2019 13:00:00 GMT
Where Will Gilead Sciences Spend Its Cash? - Motley Fool
Where Will Gilead Sciences Spend Its Cash? Motley Fool Gilead Sciences (NASDAQ:GILD) intends to augment its late-stage clinical pipeline and/or product portfolio through a bolt-on acquisition soon, according to ...
Wed, 08 May 2019 17:23:00 GMT
Generic HIV prevention drug coming in 2020, Gilead says - CNBC
Generic HIV prevention drug coming in 2020, Gilead says CNBC Following a campaign by activists, Gilead announced a generic version of Truvada, or PrEP, will be available in September 2020, a year earlier than expected.
Fri, 03 May 2019 12:00:00 GMT
Has Gilead Sciences Turned the Corner? - Yahoo Finance
Has Gilead Sciences Turned the Corner? Yahoo Finance Gilead Sciences (NASDAQ: GILD) surprised the investing community yesterday by actually beating consensus estimates for its non-GAAP earnings per share for ...
Fri, 26 Apr 2019 07:00:00 GMT
Biotech News Recap: Gilead Sciences' STELLAR Data Falls Short - Seeking Alpha
Biotech News Recap: Gilead Sciences' STELLAR Data Falls Short Seeking Alpha Failure of STELLAR-3 trial in NASH didn't come as surprise, given selonsertib's disappointing performance in the STELLAR-4 trial. Gilead continues to pursue ...
Tue, 30 Apr 2019 07:00:00 GMT
Gilead Sciences CFO Robin Washington to Retire - Wall Street Journal
Gilead Sciences CFO Robin Washington to Retire Wall Street Journal The biopharmaceutical company said Ms. Washington will step down as CFO on March 1, 2020, after more than a decade in the role.
Thu, 02 May 2019 20:31:00 GMT
Gilead to separate Kite cell therapy unit, posts higher profit - Reuters
Gilead to separate Kite cell therapy unit, posts higher profit Reuters Gilead Sciences Inc, which hired Roche veteran Daniel O'Day to be its new chief executive, on Thursday said Kite Pharma, the cancer-focused cell therapy ...
Thu, 09 May 2019 18:10:00 GMT
Where Do These Stocks Go From Here? – Mylan N.V. (MYL), Gilead Sciences, Inc. (GILD) - Post Analyst
Where Do These Stocks Go From Here? – Mylan N.V. (MYL), Gilead Sciences, Inc. (GILD) Post Analyst Investors making a wish list of stocks to watch should take a look at Mylan N.V. (NASDAQ:MYL). The stock is offering a price-to-sales ratio of 1.71. This situation ...
Wed, 24 Apr 2019 07:00:00 GMT
Gilead Sciences Isn't Satisfied With Only A Few NASH Deals, Presses On With More - Seeking Alpha
Gilead Sciences Isn't Satisfied With Only A Few NASH Deals, Presses On With More Seeking Alpha Gilead Sciences announced a NASH deal with a biotech by the name of insitro in a deal worth up to $1 billion. The reason for the collaboration deal is to use in.
Tue, 30 Apr 2019 07:00:00 GMT
HIV Patients Claim Pharmaceutical Giant Gilead Sciences Held Back Safer Drug - MedShadow
HIV Patients Claim Pharmaceutical Giant Gilead Sciences Held Back Safer Drug MedShadow More than 50 patients have filed lawsuits, alleging that Gilead Sciences has prioritized financial gains over safety as its HIV antiretroviral drugs have led to ...